CPC C07K 16/2887 (2013.01) [A61K 47/02 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01)] | 22 Claims |
1. A pharmaceutical formulation comprising a composition comprising a population of anti-CD20 antibody proteins, wherein the anti-CD20 antibody proteins in the population are expressed from one or more nucleic acid sequences encoding a heavy chain comprising the amino acid sequence of SEQ ID NO:1 and a light chain comprising the amino acid sequence of SEQ ID NO:2, wherein the population of anti-CD20 antibody proteins has an N-glycan profile comprising 10 to 20% galactosylated glycans and 20 to 40% fucosylated glycans, wherein the anti-CD20 antibody proteins are present in the pharmaceutical formulation at a concentration of 10 mg/mL to 50 mg/mL.
|